IMI (LON:IMI)‘s stock had its “add” rating reissued by research analysts at Peel Hunt in a research note issued to investors on Thursday.
Other analysts also recently issued reports about the company. Liberum Capital downgraded IMI to a “sell” rating in a research report on Thursday. HSBC raised IMI to a “buy” rating and raised their target price for the stock from GBX 1,200 ($15.68) to GBX 1,350 ($17.64) in a research report on Friday, July 13th. Numis Securities reissued an “add” rating and issued a GBX 1,400 ($18.29) target price on shares of IMI in a research report on Wednesday, August 1st. Deutsche Bank reissued a “buy” rating on shares of IMI in a research report on Thursday, August 2nd. Finally, Jefferies Financial Group reissued a “buy” rating on shares of IMI in a research report on Wednesday, September 5th. Two research analysts have rated the stock with a sell rating, seven have issued a hold rating and five have given a buy rating to the stock. IMI has a consensus rating of “Hold” and a consensus price target of GBX 1,247.31 ($16.30).
IMI stock traded down GBX 38.50 ($0.50) during mid-day trading on Thursday, reaching GBX 942 ($12.31). 1,871,645 shares of the company’s stock were exchanged, compared to its average volume of 997,118. IMI has a one year low of GBX 1,093 ($14.28) and a one year high of GBX 1,453 ($18.99).
IMI Company Profile
IMI plc designs, manufactures, and services engineered products that control the precise movement of fluids worldwide. The company's IMI Critical Engineering division offers critical flow control solutions. It provides anti-surge valve and actuator systems to liquefied natural gas compression facilities; integrated flow control systems for critical applications in fluid catalytic cracking; valves into the ethylene and polypropylene production processes, as well as delayed coking; actuation systems to operate industrial valves; and turbine by-pass valves for conventional and nuclear power plants.
Receive News & Ratings for IMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IMI and related companies with MarketBeat.com's FREE daily email newsletter.